This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73889487
rdf:type
wikibase:Item
schema:description
articolo scientifico (pubblicato il 1999) im Jahr 1999 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в січні 1999 artikull shkencor i botuar më 01 janar 1999 artículu científicu espublizáu en xineru de 1999 գիտական հոդված հրատարակված 1999 թվականի հունվարի 1-ին scientific article published on 01 January 1999 wetenschappelijk artikel
p:P577
wds:Q73889487-C9FB5683-806E-4FA2-8BFB-A9D6381466A3
wdt:P577
1999-01-01T00:00:00Z
p:P2093
wds:Q73889487-1E9608C5-5DBE-4D33-85AC-D147B075C226 wds:Q73889487-29EB9850-2629-4EB5-AB41-7315A92E2140 wds:Q73889487-35189FA8-1B38-48F3-A57D-B9B4143C3AC1 wds:Q73889487-75EF6347-6BFE-4FD0-9D84-3089CE4730F3
wdt:P2093
Gleave ME Taylor D Goldenberg SL Bruchovsky N
rdfs:label
Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up
skos:prefLabel
Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up
schema:name
Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up
p:P1476
wds:Q73889487-6B9AA4BF-5ECE-4016-AE79-D7CD581D985F
wdt:P1476
Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up
p:P304
wds:Q73889487-92554CCC-3D55-491C-A5B2-4C29C124779F
wdt:P304
287-292
p:P31
wds:Q73889487-B026DA34-A1CA-42DC-9FC9-8F2FCE23C852
wdt:P31
wd:Q13442814
p:P921
wds:Q73889487-DE8269FB-EA75-4956-AA1E-2E3978AE2F35
wdt:P921
wd:Q181257
p:P698
wds:Q73889487-E90C83C0-2E9F-49AB-A25E-9C7D60AEB822
wdtn:P698
n10:10851335
wdt:P698
10851335
p:P1433
wds:Q73889487-8EF68ED8-CCDB-43FC-98E0-79E5EEB5DF60
wdt:P1433
wd:Q27714678
p:P433
wds:Q73889487-7C173357-2A60-47DA-B253-9AD6472042DE
p:P478
wds:Q73889487-6EBEB1AF-C8EA-441D-941C-740F576EE2E7
wdt:P433
3
wdt:P478
3